Addition of Docetaxel to Hormonal Therapy in Low- and High-Burden Metastatic Hormone Sensitive Prostate Cancer: Long-Term Survival Results from the STAMPEDE Trial. N W Clarke , A Ali , F C Ingleby , A Hoyle , C L Amos , G Attard , C D Brawley , J Calvert , S Chowdhury , A Cook , W Cross , D P Dearnaley , H Douis , D Gilbert , S Gillessen , R J Jones , R E Langley , A MacNair , Z Malik , M D Mason , D Matheson , R Millman , C , A W S Ritchie , H Rush , J M Russell , J Brown , S Beesley , A Birtle , L Capaldi , J Gale , S Gibbs , A Lydon , A Nikapota , A Omlin , J M O'Sullivan , O Parikh , A Protheroe , S Rudman , N , M Simms , J S Tanguay , S Tolan , J Wagstaff , J Wallace , J Wylie , A Zarkar , M R Sydes , M K B Parmar , N D James Annals of oncology（2020）
关键词
Metastatic Prostate Cancer
AI 理解论文
溯源树
样例
